Related Experiment Video
Updated: May 10, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling
Xing Huang1, Zhengsheng Wu, Yide Mei
1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, China.
Abstract:
The primary role of autophagy is adaption to starvation. However, increasing evidence suggests that autophagy inhibition also plays an important role in tumorigenesis. Upregulation of X-linked inhibitor of apoptosis (XIAP) has been associated to a variety of human cancers, yet the underlying mechanisms remain obscure. Here, we report that XIAP suppresses autophagy by exerting a previously unidentified ubiquitin E3 ligase activity towards Mdm2, which is a negative regulator of p53. XIAP controls serum starvation-induced autophagy downstream of the PI3K/Akt pathway. In mouse models, inhibition of autophagy by XIAP promotes tumorigenecity of HCT116 cells. XIAP-mediated autophagy inhibition is also largely validated in clinical tumour samples. These findings reveal a novel XIAP-Mdm2-p53 pathway that mediates the inhibition of autophagy, by which XIAP may contribute to tumorigenesis.
Insights
X-linked inhibitor of apoptosis (XIAP) suppresses autophagy via Mdm2, impacting p53 regulation. This XIAP-Mdm2-p53 pathway inhibition of autophagy promotes tumor growth, as seen in mouse models and human cancer samples.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Autophagy is crucial for starvation adaptation, but its inhibition is implicated in tumorigenesis.
- X-linked inhibitor of apoptosis (XIAP) is upregulated in various cancers, with unclear mechanisms.
- Understanding XIAP's role in cancer progression is vital.
Purpose of the Study:
- To elucidate the mechanism by which XIAP influences autophagy.
- To investigate the role of XIAP-mediated autophagy inhibition in tumorigenesis.
- To identify novel therapeutic targets in XIAP-associated cancers.
Main Methods:
- Investigated XIAP's ubiquitin E3 ligase activity towards Mdm2.
- Analyzed autophagy regulation downstream of the PI3K/Akt pathway.
- Utilized mouse models (HCT116 cells) and clinical tumor samples to validate findings.
Main Results:
- XIAP suppresses autophagy through its E3 ligase activity on Mdm2, a p53 regulator.
- XIAP controls autophagy induction by serum starvation, acting downstream of PI3K/Akt.
- XIAP-induced autophagy inhibition promotes tumor formation in mouse models.
- XIAP-mediated autophagy suppression is confirmed in clinical tumor samples.
Conclusions:
- A novel XIAP-Mdm2-p53 pathway inhibits autophagy.
- XIAP contributes to tumorigenesis by suppressing autophagy.
- This pathway represents a potential therapeutic target for XIAP-associated cancers.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
